The Clinical Impact of Methylene Tetrahydrofolate Reductase Polymorphism on the Vascular Complications of Sickle Cell Disease

Faten Ramadan Abdou;

Abstract


Sickle cell disease (SCD) is one of the most common inherited
diseases worldwide, mainly among people of African origin.
The vascular complications underly the clinical manifestations of the
disease and are of an important aspect of the clinical spectr


Other data

Title The Clinical Impact of Methylene Tetrahydrofolate Reductase Polymorphism on the Vascular Complications of Sickle Cell Disease
Authors Faten Ramadan Abdou
Keywords The Clinical Impact of Methylene Tetrahydrofolate Reductase Polymorphism on the Vascular Complications of Sickle Cell Disease
Issue Date 2008
Description 
Sickle cell disease (SCD) is one of the most common inherited
diseases worldwide, mainly among people of African origin.
The vascular complications underly the clinical manifestations of the
disease and are of an important aspect of the clinical spectr

Attached Files

File SizeFormat
9782Dr. Faten Ramadan Abdou.pdf351.07 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.